| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Herman Alan C. is a Chief Scientific Officer at Coherus Oncology, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $75K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 17,535 | $15.02 | $263,300.30 | -26.1% | |
| Jul 5, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 600 | $15.00 | $9,000.00 | -0.9% | |
| Jun 1, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $20.32 | $230,291.84 | -7.6% | |
| May 1, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $20.00 | $226,626.00 | -12.5% | |
| Apr 3, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $20.73 | $234,985.22 | -11.1% | |
| Mar 1, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $24.19 | $274,171.34 | -10.0% | |
| Feb 1, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $27.37 | $310,154.74 | -9.1% | |
| Jan 3, 2017 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $27.95 | $316,722.45 | -4.3% | |
| Dec 1, 2016 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $27.40 | $310,523.10 | -3.9% | |
| Nov 1, 2016 | CHRS Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 11,333 | $27.53 | $312,041.69 | -7.2% |